本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.85
-0.1600-7.96%
盘后:1.870.0200+1.08%19:12 EDT
成交量:90.12万
成交额:170.95万
市值:2.21亿
市盈率:-1.32
高:2.00
开:1.99
低:1.85
收:2.01
52周最高:5.55
52周最低:1.03
股本:1.20亿
流通股本:1.09亿
量比:0.92
换手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-1.4029
每股收益(LYR):-1.2813
净资产收益率:-179.10%
总资产收益率:-62.95%
市净率:19.34
市盈率(LYR):-1.44

数据加载中...

公司资料

公司名字:
Pyxis Oncology, Inc.
交易所:
NASDAQ
成立时间:
2018
员工人数:
56
公司地址:
321 Harrison Avenue,11th Floor, Suite 1,Boston,Massachusetts,United States
邮编:
02118
电话:
传真:
- -
简介:
Pyxis Oncology, Inc.于2018年6月11日在特拉华州注册成立。该公司是一家临床阶段的肿瘤学公司,推进专注于解决实体瘤患者未满足的医疗需求的发展战略,并立即关注头颈部鳞状细胞癌(HNSCC)。

董事

名称
职位
John Flavin
Chairman of the Board
Lara Sullivan
Chief Medical Officer, Chief Executive Officer, President and Director
Darren Cline
Independent Director
Freda Lewis Hall
Independent Director
Jakob Dupont
Independent Director
Michael A. Metzger
Independent Director
Rachel Humphrey
Independent Director
Santhosh Palani
Independent Director
Thomas Civik
Independent Director

股东

名称
职位
Lara Sullivan
Chief Medical Officer, Chief Executive Officer, President and Director
Jitendra Wadhane
Principal Financial Officer and Chief Accounting Officer